To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: AANS: Spinal Cord Stimulation More Cost-effective than Conventional Pain Therapy for Failed-Back Syndrome URL: http://www.pslgroup.com/dg/21506A.htm Doctor's Guide April 9, 2002
By W. A. Thomasson Special to DG News
CHICAGO, IL -- April 9, 2002 -- Over a five-year period, the chronic pain of failed-back syndrome can be relieved more effectively and at lower cost using electrical stimulation of the spinal cord (SCS) than by conventional pain therapy, according to a study presented here yesterday at the annual meeting of the American Association of Neurological Surgeons (AANS).
Krishna Kumar, MD, of the University of Saskatchewan, Regina, Saskatchewan, Canada, said that in contrast to most previous attempts to address this question, this study was based on the actual treatment experiences of 104 patients followed for five years.
At entry, patients had had a median of 3.3 operations and had been out of work for at least one year.
Sixty of the patients had electrodes implanted for SCS while the remaining 44 were treated conservatively with conventional pain therapy. SCS provided somewhat superior pain control and improved quality of life; no patient required hospitalization for breakthrough pain, versus an average of three days hospitalization in patients treated conventionally. Fifteen percent were able to return to work.
Analysis showed that the total five-year cost of SCS was C$28,665, while that of conventional therapy was C$38,029. The cost of SCS was initially higher, due to the expenses associated with surgical implantation of the electrodes, but by the end of 2.5 years this had been more than offset by the lower cost of drugs and fewer contacts with physicians and other healthcare professionals. The cost advantage of SCS continued throughout the remainder of the five years, despite most patients having to have their electrodes replaced at some point.
Dr. Kumar noted that projections suggest the advantage would be still greater at 10 years, and that results would be even better if manufacturers could reduce the cost of the SCS equipment and/or make the electrodes more durable. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.